Research Tracker›Biomarker Atlas›PACVS›2P proteotypic peptides (K986P/V987P)

2P proteotypic peptides (K986P/V987P) in PACVS

2P proteotypic peptides (K986P/V987P), also described as Vaccine-encoded spike signature, is a molecular marker reported as elevated in PACVS (PACVS, PCVS) when patients are compared with Wild-type viral spike. Symptom domains tied to this marker in the source include confirms vaccine-derived spike origin. The finding is drawn from Sutton et al. 2023; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedMolecular

Summary

Direction in PACVS↑ Elevated — higher than in the comparison group
CategoryMolecular
Also described asVaccine-encoded spike signature
Compared againstWild-type viral spike
Associated symptomsConfirms vaccine-derived spike origin
Test typeClinical or physiological test
SourceSutton et al. 2023 — doi:10.1016/j.vaccine.2023.04.044
Condition atlasPACVS Biomarker Atlas

Related Molecular markers in PACVS

Full list: PACVS Biomarker Atlas.

Frequently asked questions

Is 2P proteotypic peptides (K986P/V987P) high or low in PACVS?

Elevated. Studies summarised in the OSMF atlas report higher 2P proteotypic peptides (K986P/V987P) in PACVS than in Wild-type viral spike. Source: Sutton et al. 2023.

What symptoms is 2P proteotypic peptides (K986P/V987P) associated with in PACVS?

The cited literature associates this marker with Confirms vaccine-derived spike origin. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures 2P proteotypic peptides (K986P/V987P)?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal 2P proteotypic peptides (K986P/V987P) result diagnostic of PACVS?

No. No single biomarker is diagnostic of PACVS. 2P proteotypic peptides (K986P/V987P) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). 2P proteotypic peptides (K986P/V987P) in PACVS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/pacvs/2p-proteotypic-peptides-k986p-v987p.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.